DK1037667T3 - Farmaceutiske hydrogelformuleringer, lægemiddelindgivelsesanordninger samt fremgangsmåder - Google Patents

Farmaceutiske hydrogelformuleringer, lægemiddelindgivelsesanordninger samt fremgangsmåder

Info

Publication number
DK1037667T3
DK1037667T3 DK98959589T DK98959589T DK1037667T3 DK 1037667 T3 DK1037667 T3 DK 1037667T3 DK 98959589 T DK98959589 T DK 98959589T DK 98959589 T DK98959589 T DK 98959589T DK 1037667 T3 DK1037667 T3 DK 1037667T3
Authority
DK
Denmark
Prior art keywords
methods
drug delivery
delivery devices
hydrogel formulations
pharmaceutical hydrogel
Prior art date
Application number
DK98959589T
Other languages
Danish (da)
English (en)
Inventor
Thomas O Murdock
Stephanus Pudjijanto
Subramanian S Venkatraman
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Application granted granted Critical
Publication of DK1037667T3 publication Critical patent/DK1037667T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Inorganic Chemistry (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Reproductive Health (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Preparation (AREA)
DK98959589T 1997-12-09 1998-12-01 Farmaceutiske hydrogelformuleringer, lægemiddelindgivelsesanordninger samt fremgangsmåder DK1037667T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/987,372 US6039977A (en) 1997-12-09 1997-12-09 Pharmaceutical hydrogel formulations, and associated drug delivery devices and methods
PCT/US1998/025120 WO1999029348A1 (en) 1997-12-09 1998-12-01 Pharmaceutical hydrogel formulations, drug delivery devices and methods

Publications (1)

Publication Number Publication Date
DK1037667T3 true DK1037667T3 (da) 2004-09-20

Family

ID=25533223

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98959589T DK1037667T3 (da) 1997-12-09 1998-12-01 Farmaceutiske hydrogelformuleringer, lægemiddelindgivelsesanordninger samt fremgangsmåder

Country Status (16)

Country Link
US (1) US6039977A (ja)
EP (1) EP1037667B1 (ja)
JP (1) JP2001525377A (ja)
KR (1) KR100568482B1 (ja)
CN (1) CN1147319C (ja)
AR (1) AR017197A1 (ja)
AT (1) ATE266422T1 (ja)
AU (1) AU1535799A (ja)
CA (1) CA2313642C (ja)
DE (1) DE69823869T2 (ja)
DK (1) DK1037667T3 (ja)
ES (1) ES2221228T3 (ja)
PT (1) PT1037667E (ja)
TW (1) TWI231214B (ja)
WO (1) WO1999029348A1 (ja)
ZA (1) ZA9810641B (ja)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6440457B1 (en) * 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
GB0005016D0 (en) * 2000-03-01 2000-04-26 Jumik Technologies Limited PVA-Containing compositions
ATE309822T1 (de) 2000-04-19 2005-12-15 Genentech Inc Formulierungen mit verzögerter freisetzung enthaltend wachstumshormon
KR100452972B1 (ko) * 2000-05-16 2004-10-14 주식회사 삼양사 경피투여용 하이드로젤 조성물
WO2002067991A1 (en) * 2001-02-23 2002-09-06 Genentech, Inc. Erodible polymers for injection
KR100856693B1 (ko) * 2001-04-04 2008-09-04 알자 코포레이션 항미생물제 양립가능성 저장소 조성물을 포함하는 경피전기수송 전달 장치
PT1397155E (pt) * 2001-06-21 2015-12-07 Genentech Inc Formulação de libertação sustentada
DE10141650C1 (de) * 2001-08-24 2002-11-28 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
ITMI20012060A1 (it) * 2001-10-05 2003-04-05 Recordati Chem Pharm Nuovi eterocilcli n-acilati
US20040023413A1 (en) * 2001-11-26 2004-02-05 Molecular Reflections, Inc. Microscale immobilization of molecules using a hydrogel and methods of use thereof
AU2003280136A1 (en) * 2002-06-28 2004-01-19 Alza Corporation A reservoir for use in an electrotransport drug delivery device
US20040158194A1 (en) * 2003-02-06 2004-08-12 Wolff Andy And Beiski Ben Z. Oral devices and methods for controlled drug release
EP1689489B1 (en) * 2003-11-19 2008-02-27 Alza Corporation Peptidically buffered formulations for electrotransport applications and methods of making
WO2005053641A1 (en) * 2003-12-05 2005-06-16 Namibia Medical Investments (Pty) Limited Patch
CN100386073C (zh) * 2004-03-03 2008-05-07 杭州民生药业集团有限公司 一种经皮给药系统
US7491263B2 (en) * 2004-04-05 2009-02-17 Technology Innovation, Llc Storage assembly
US20060135906A1 (en) * 2004-11-16 2006-06-22 Akihiko Matsumura Iontophoretic device and method for administering immune response-enhancing agents and compositions
US20070106138A1 (en) * 2005-05-26 2007-05-10 Beiski Ben Z Intraoral apparatus for non-invasive blood and saliva monitoring & sensing
EP1893278A2 (en) * 2005-06-03 2008-03-05 Trans-Dermal Patents Company, LLC Agent delivery system
US20090143761A1 (en) * 2005-06-03 2009-06-04 Transdermal Patents Company, Llc Agent delivery system and uses of same
EP1905433A1 (en) * 2005-07-15 2008-04-02 Transcu Ltd. Percutaneous absorption patch with application position indicating function, and iontophoresis device
JP4969812B2 (ja) * 2005-07-22 2012-07-04 久光製薬株式会社 ハイドロゲル組成物
US20070060861A1 (en) * 2005-08-31 2007-03-15 Subramony Janardhanan A Cathode for electrotransport delivery of anionic drug
WO2007041322A2 (en) * 2005-09-30 2007-04-12 Tti Ellebeau, Inc. Iontophoretic delivery of active agents conjugated to nanoparticles
JP2009522011A (ja) 2005-12-30 2009-06-11 Tti・エルビュー株式会社 活性物質を生体界面に送達するイオントフォレーシスシステム、装置及び方法
CN101405051A (zh) * 2006-03-21 2009-04-08 阿尔扎公司 用于药物电转运的可水化聚合酯基质
US8246973B2 (en) * 2006-06-21 2012-08-21 Advanced Cardiovascular Systems, Inc. Freeze-thaw method for modifying stent coating
CA2661912A1 (en) * 2006-08-29 2008-03-06 Alza Corporation Drug electrotransport with hydration measurement of hydratable reservoir
US7538652B2 (en) * 2006-08-29 2009-05-26 International Business Machines Corporation Electrical component tuned by conductive layer deletion
US20080193514A1 (en) * 2006-11-02 2008-08-14 Transcu Ltd. Compostions and methods for iontophoresis delivery of active ingredients through hair follicles
US20080154230A1 (en) * 2006-12-20 2008-06-26 Janardhanan Anand Subramony Anode for electrotransport of cationic drug
EP2123259A1 (en) * 2007-01-16 2009-11-25 Hokkaido University Liposome preparation for iontophoresis having antioxidant component encapsulated therein
US20080234627A1 (en) * 2007-03-22 2008-09-25 Wanda Dent Pivotally engaged multiple part electrotransport drug delivery device
US20080286349A1 (en) * 2007-05-18 2008-11-20 Youhei Nomoto Systems, devices, and methods for passive transdermal delivery of active agents to a biological interface
JP2010187707A (ja) * 2007-06-12 2010-09-02 Hokkaido Univ インスリンを封入したイオントフォレーシス用リポソーム製剤
US20090043244A1 (en) * 2007-08-08 2009-02-12 Inan Omer T Electrotransport Drug Delivery Device Adaptable to Skin Resistance Change
US20090105634A1 (en) * 2007-10-17 2009-04-23 Alza Corporation Anodic Reservoir for Electrotransport of Cationic Drug
US20090105632A1 (en) * 2007-10-18 2009-04-23 Padmanabhan Rama V Electrotransport Of Lisuride
US20090312689A1 (en) * 2008-06-05 2009-12-17 Alza Corporation Adjustable Current Electrotransport Fentanyl Delivery Device
WO2010030738A2 (en) * 2008-09-10 2010-03-18 Transcu Ltd. Apparatus and method to dispense hpc-based viscous liquids into porous substrates, e.g., continuous web-based process
US8048442B1 (en) 2008-09-16 2011-11-01 Abbott Cardiovascular Systems Inc. Modified heparin-based coatings and related drug eluting stents
US8428708B1 (en) 2012-05-21 2013-04-23 Incline Therapeutics, Inc. Self-test for analgesic product
US8428709B1 (en) 2012-06-11 2013-04-23 Incline Therapeutics, Inc. Current control for electrotransport drug delivery
US8301238B2 (en) 2011-03-31 2012-10-30 Incline Therapeutics, Inc. Two-part electrotransport device
US9855211B2 (en) * 2013-02-28 2018-01-02 Novan, Inc. Topical compositions and methods of using the same
US10478498B2 (en) 2014-06-20 2019-11-19 Reform Biologics, Llc Excipient compounds for biopolymer formulations
GB2533827B (en) * 2015-05-21 2016-12-21 Gateway Devices Ltd Intravenous access device
US20170136180A1 (en) * 2015-09-25 2017-05-18 Massachusetts Institute Of Technology Stretchable, Robust and Biocompatible Hydrogel Electronics and Devices
KR20190027878A (ko) 2016-07-13 2019-03-15 리폼 바이오로직스, 엘엘씨 치료 단백질 제제용 안정화 부형제
CN106491517B (zh) * 2016-11-23 2019-12-06 佛山科学技术学院 吡非尼酮pva水凝胶的制备方法及吡非尼酮pva水凝胶

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1181915A (en) * 1981-02-05 1985-02-05 Nippon Oil Co., Ltd. Process for preparing a hydrogel
DE3278911D1 (en) * 1981-05-16 1988-09-22 Nippon Oil Co Ltd Process for the preparation of gel for use as cooling medium
US4542013A (en) * 1981-07-08 1985-09-17 Key Pharmaceuticals, Inc. Trinitroglycerol sustained release vehicles and preparation therefrom
US4593053A (en) * 1984-12-07 1986-06-03 Medtronic, Inc. Hydrophilic pressure sensitive biomedical adhesive composition
JPS61218517A (ja) * 1985-03-25 1986-09-29 Bio Materiaru Yunibaasu:Kk 経皮吸収製剤
EP0303445A1 (en) * 1987-08-13 1989-02-15 Walton S.A. Clebopride transdermal patch
JPH0720544B2 (ja) * 1988-12-27 1995-03-08 日本石油株式会社 Pvaヒドロゲルの製造法及びmriファントム
US5091185A (en) * 1990-06-20 1992-02-25 Monsanto Company Coated veterinary implants
EP0516026A1 (en) * 1991-05-28 1992-12-02 Takeda Chemical Industries, Ltd. Hydrogel and method of producing same
US5260066A (en) * 1992-01-16 1993-11-09 Srchem Incorporated Cryogel bandage containing therapeutic agent
WO1998008492A1 (en) * 1996-08-29 1998-03-05 Novo Nordisk A/S Transdermal delivery of peptides
US6650934B2 (en) * 1996-12-17 2003-11-18 Alza Corp Polymeric foam reservoirs for an electrotransport delivery device

Also Published As

Publication number Publication date
ES2221228T3 (es) 2004-12-16
JP2001525377A (ja) 2001-12-11
US6039977A (en) 2000-03-21
KR100568482B1 (ko) 2006-04-07
EP1037667B1 (en) 2004-05-12
ZA9810641B (en) 1999-05-24
CA2313642C (en) 2008-09-30
DE69823869T2 (de) 2005-05-19
CN1147319C (zh) 2004-04-28
KR20010032839A (ko) 2001-04-25
TWI231214B (en) 2005-04-21
CN1281372A (zh) 2001-01-24
AR017197A1 (es) 2001-08-22
DE69823869D1 (de) 2004-06-17
PT1037667E (pt) 2004-08-31
WO1999029348A1 (en) 1999-06-17
AU1535799A (en) 1999-06-28
EP1037667A1 (en) 2000-09-27
CA2313642A1 (en) 1999-06-17
ATE266422T1 (de) 2004-05-15

Similar Documents

Publication Publication Date Title
DK1037667T3 (da) Farmaceutiske hydrogelformuleringer, lægemiddelindgivelsesanordninger samt fremgangsmåder
NO994837D0 (no) Intravesikal medikamentavleveringssystem
DE69812089D1 (de) Pharmazeutische omeprazol-formulierung
PL325774A1 (en) Drug delivery system for two or more active substances
ATE289500T1 (de) Ophtalmologische medikamentenzuführvorrichtung
DK1473003T3 (da) Lægemiddeladministrationsanordning
MA26549A1 (fr) Medicaments
ATE548029T1 (de) Wirkstoffabgabevorrichtung mit verzögerter freisetzung
EE9800025A (et) Transkorneaalne süsteem ravimite manustamiseks
NO20004196L (no) Innretninger for legemiddelavlevering
BR9607851B1 (pt) combinaÇço e formulaÇço farmacÊutica.
ATE291417T1 (de) Gastrointestinales wirkstoffverabreichungssystem
DZ2371A1 (fr) Formulations pharmaceutiques pour la distribution prolongée de médicaments.
NO961136D0 (no) Farmasöytisk formuleringsgrunnlag for nano-suspensjoner
HUP0104168A3 (en) Spray on bandage and drug delivery system
EE05506B1 (et) Ravimi manustamise vahend eriti progestiinide ja”strogeenide manustamiseks
EP1036573A4 (en) DEVICE FOR ADMINISTERING A SUBSTANCE THROUGH THE SKIN OR A MUCUTINE
DE60037816D1 (de) Pharmazeutische formulierung enthaltend megalatran und dessen pro-pharmaka
DE1003485T1 (de) Mikroosmotisches gesteuertes arzneistoffabgabesysteme
GB9714750D0 (en) Drug delivery device
ZA200007111B (en) Methods and devices for providing prolonged drug therapy.
DE69634569D1 (de) Medikamentenabgabevorrichtung
DK1183061T3 (da) Lægemiddelafgivelsessystem
FI970053A0 (fi) Transdermaalinen lääkeaineen antosysteemi
DE29520419U1 (de) Arzneimittel-Dosiervorrichtung